These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15806187)

  • 1. Screening for prostate cancer: a response to four letters.
    Lamb D; Delahunt B
    N Z Med J; 2005 Apr; 118(1212):U1390. PubMed ID: 15806187
    [No Abstract]   [Full Text] [Related]  

  • 2. Regarding 'Prostate cancer screening--finding the middle road forward' editorial.
    Richardson A
    N Z Med J; 2005 Feb; 118(1210):U1332. PubMed ID: 15776103
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for prostate cancer: a patient's view.
    N Z Med J; 2005 Apr; 118(1213):U1419. PubMed ID: 15843847
    [No Abstract]   [Full Text] [Related]  

  • 4. Regarding 'Prostate cancer screening--finding the middle road forward' editorial.
    Brunton CR
    N Z Med J; 2005 Feb; 118(1210):U1334. PubMed ID: 15776104
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostate cancer screening: is it possible to explain diametrically opposed views?
    Richardson A
    N Z Med J; 2005 Feb; 118(1209):U1289. PubMed ID: 15711622
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical practice. Screening for prostate cancer.
    Hoffman RM
    N Engl J Med; 2011 Nov; 365(21):2013-9. PubMed ID: 22029754
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate-specific antigen screening for prostate cancer: a decision-analytical perspective.
    Hayes JH; Barry MJ; Kantoff PW; Stahl JE
    BJU Int; 2007 Sep; 100(3):486-8. PubMed ID: 17669139
    [No Abstract]   [Full Text] [Related]  

  • 8. Application of prostate-specific antigen in prostate cancer.
    Liang SL
    MLO Med Lab Obs; 2008 Oct; 40(10):54, 56-7. PubMed ID: 18988558
    [No Abstract]   [Full Text] [Related]  

  • 9. [Based on current knowledge the introduction of the PSA screening for prostatic cancer is unethical].
    Krantz I; Sachs L; Ahlberg BM; Nordin P; Nilstun T
    Lakartidningen; 2005 Sep 5-11; 102(36):2498-500. PubMed ID: 16196436
    [No Abstract]   [Full Text] [Related]  

  • 10. Storm over screening for prostate specific antigen. Give men facts on prostate cancer.
    Darracott Vaughan E; McLeod DG
    BMJ; 2002 Jun; 324(7350):1392. PubMed ID: 12053924
    [No Abstract]   [Full Text] [Related]  

  • 11. [PSA based screening for prostatic cancer].
    Johansen TE
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2612-4. PubMed ID: 19023357
    [No Abstract]   [Full Text] [Related]  

  • 12. Verification bias in screening for prostate cancer.
    Leiner S
    N Engl J Med; 2003 Oct; 349(17):1672-3; author reply 1672-3. PubMed ID: 14573742
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for prostate cancer: the view of the Prostate Awareness and Support Society's President.
    Young B
    N Z Med J; 2005 Apr; 118(1212):U1392. PubMed ID: 15806188
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidental acute prostatic inflammation is associated with a lower percentage of free prostate-specific antigen than other benign conditions of the prostate: a prospective screening study.
    Rowe EW; Laniado ME; Walker MM; Anup P
    BJU Int; 2006 May; 97(5):1039-42. PubMed ID: 16643488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies regarding screening for prostate cancer.
    Crawford ED; Thompson IM
    BJU Int; 2007 Jul; 100 Suppl 2():5-7. PubMed ID: 17594348
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for prostate cancer.
    Hensel WA
    N Engl J Med; 1996 Mar; 334(10):667; author reply 667-8. PubMed ID: 8592543
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostate cancer screening is experimental.
    Cox B
    N Z Med J; 1996 Mar; 109(1017):63-4. PubMed ID: 8606819
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prostate-specific antigen--the most important cancer marker. Diagnostics and follow up of prostatic cancer have changed].
    Bratt O; Björk T
    Lakartidningen; 2007 Nov 14-20; 104(46):3460-4. PubMed ID: 18072615
    [No Abstract]   [Full Text] [Related]  

  • 19. [The unreasonableness of prostate-cancer screening and the ethical problems pertaining to its investigation].
    Bonneux L
    Ned Tijdschr Geneeskd; 2005 Apr; 149(18):966-71. PubMed ID: 15903036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the era of prostate-specific antigen over?
    Djavan B; Rocco B; Stangelberger A; De Cobelli O; Marberger M
    BJU Int; 2007 Jul; 100 Suppl 2():8-10. PubMed ID: 17594349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.